Yahoo · Nov 3, 2026
Bavarian Nordic secures four-year UK vaccine supply deal
MVA-BN is indicated for use in individuals from the age of two years considered at smallpox or mpox infection risk.
OTC · BVNRY
Bavarian Nordic A/S
Healthcare · Biotechnology
$12.25
Down-$0.08 (-0.65%)
Updated Nov 5, 2026, 4:15 PM
SID Score
5.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.34B
- P/E ratio
- 6.19
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 1.33K
- Avg. volume
- 3.87K
Price performance · BVNRY
BVNRY price history
1M range · 0 trading sessions · Daily adjusted prices
BVNRY does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest BVNRY news
The latest Smart Investors Daily articles mentioning BVNRY.
Stock researchResearch & News · News
Company
Market Activity
Research & News
Loading stock research…